ICAM-1988

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596796

CAS#: 444169-80-6

Description: ICAM-1988 is an LFA-1 antagonist.


Chemical Structure

img
ICAM-1988
CAS# 444169-80-6

Theoretical Analysis

MedKoo Cat#: 596796
Name: ICAM-1988
CAS#: 444169-80-6
Chemical Formula: C22H22Cl2N4O6S
Exact Mass: 540.06
Molecular Weight: 541.400
Elemental Analysis: C, 48.81; H, 4.10; Cl, 13.10; N, 10.35; O, 17.73; S, 5.92

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: ICAM-1988; ICAM 1988; ICAM1988;

IUPAC/Chemical Name: (S)-2-(2,6-dichloro-4-(((E)-3-(furan-2-yl)acrylamido)methyl)benzamido)-3-((R)-thiazolidine-4-carboxamido)propanoic acid

InChi Key: NKAQYHXMQJFUKQ-RYTMFUSVSA-N

InChi Code: InChI=1S/C22H22Cl2N4O6S/c23-14-6-12(8-25-18(29)4-3-13-2-1-5-34-13)7-15(24)19(14)21(31)28-16(22(32)33)9-26-20(30)17-10-35-11-27-17/h1-7,16-17,27H,8-11H2,(H,25,29)(H,26,30)(H,28,31)(H,32,33)/b4-3+/t16-,17-/m0/s1

SMILES Code: O=C(O)[C@H](CNC([C@H]1NCSC1)=O)NC(C2=C(Cl)C=C(CNC(/C=C/C3=CC=CO3)=O)C=C2Cl)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 541.40 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Velarde GP, Sherazi S, Kraemer DF, Bravo-Jaimes K, Butterfield R, Amico T, Steinmetz SD, Guzman M, Martin D, Dodani S, Smith BH. Clinical and Biochemical Markers of Cardiovascular Structure and Function in Women With the Metabolic Syndrome. Am J Cardiol. 2015 Dec 1;116(11):1705-10. doi: 10.1016/j.amjcard.2015.09.010. Epub 2015 Sep 16. PubMed PMID: 26482181.

2: Van der Donckt C, Roth L, Vanhoutte G, Blockx I, Bink DI, Ritz K, Pintelon I, Timmermans JP, Bauters D, Martinet W, Daemen MJ, Verhoye M, De Meyer GR. Fibrillin-1 impairment enhances blood-brain barrier permeability and xanthoma formation in brains of apolipoprotein E-deficient mice. Neuroscience. 2015 Jun 4;295:11-22. doi: 10.1016/j.neuroscience.2015.03.023. Epub 2015 Mar 19. PubMed PMID: 25797463.

3: Kirmizis D, Papagianni A, Dogrammatzi F, Belechri AM, Alexopoulos E, Efstratiadis G, Memmos D. The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis. Ren Fail. 2012;34(9):1135-9. doi: 10.3109/0886022X.2012.717484. Epub 2012 Sep 6. PubMed PMID: 22950641.

4: Ganem F, Serrano CV Jr, Fernandes JL, Blotta MH, Souza JA, Nicolau JC, Ramires JA, Hueb WA. Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery. Interact Cardiovasc Thorac Surg. 2011 May;12(5):778-83. doi: 10.1510/icvts.2010.255257. Epub 2011 Feb 5. PubMed PMID: 21297144.

5: Mendez MP, Monroy YK, Du M, Preston AM, Tolle L, Lin Y, VanDussen KL, Samuelson LC, Standiford TJ, Curtis JL, Beck JM, Christensen PJ, Paine R 3rd. Overexpression of sICAM-1 in the alveolar epithelial space results in an exaggerated inflammatory response and early death in Gram negative pneumonia. Respir Res. 2011 Jan 19;12:12. doi: 10.1186/1465-9921-12-12. PubMed PMID: 21247482; PubMed Central PMCID: PMC3034680.

6: Ottaviani C, Shapiro D, Davydov DM, Goldstein IB, Mills PJ. The autonomic phenotype of rumination. Int J Psychophysiol. 2009 Jun;72(3):267-75. doi: 10.1016/j.ijpsycho.2008.12.014. Epub 2009 Jan 15. PubMed PMID: 19272312.

7: Khojasteh SC, Leipold DD, Lai F, La H, Baumgardner MJ, Desino KE, Gudmundsson OS, Bloedow DC, Bodary SC, Reynolds ME, Gadek TR, Kenkare-Mitra S. Preclinical absorption, distribution, metabolism and excretion (ADME) characterization of ICAM1988, an LFA-1/ICAM antagonist, and its prodrug. Xenobiotica. 2008 Mar;38(3):340-52. doi: 10.1080/00498250701813248 . PubMed PMID: 18274961.